Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
December 04, 2009
IN THIS ISSUE
EC variations regulation
FDA interview
Green opportunities
Sanofi in Russian project
Boosting bioprocessing
Join PTE on LinkedIn!
More...

UK adopts EC variations regulation
Guidance has been published in the UK regarding a new European variations regulation that comes into effect on 1 January 2010. More...

After 20 years, ICH tops harmonization efforts
Pharmaceutical Technology talks to FDA's Justina A. Molzon about current discussions with international regulators, and how, after 20 years of harmonization activities and the common technical document, the ICH has benefited regulatory authorities. More...

Businesses miss out on green opportunities
European business leaders are missing opportunities to reduce their environmental footprint and drive efficiencies through document governance, according to research from Ricoh, an electronic solutions provider. More...

Sanofi-aventis plans participation in Russian project
Sanofi-aventis has signed a memorandum of understanding (MoU) with Prominvest, a fully owned subsidiary of the Russian State Corporation Rostekhnologii, confirming its intent to participate in the Pharmpolis Project. More...

Cash boost for UK bioprocessing
The private industry has been urged to join a public sector commitment fund in the UK to advance manufacturing R&D in bioprocessing, following the investment of approximately £9 million from two UK research councils. More...

USP revises standard to prevent medication errors
The US Pharmacopeial Convention (USP) has posted a proposed revised standard for what should and should not appear on the ferrules and cap overseals of medication vials. More...

Podcast: Vetter Development Service Chicago
In order to minimize risks and take advantage of opportunities, you need comprehensive know-how and years of experience. Vetter, as a specialist in the aseptic filling of injection systems, can manufacture preclinical, Phase I and Phase II clinical batches from its new facilities in Chicago. We invite you to find out more about Vetter Development Services USA Inc. More...

Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...

Product Profile
Watson Marlow
  Peristaltic Pump Technology

Peristaltic pumps are at the centre of many single-use biopharmaceutical processes and medical/surgical instruments. Their non-contacting design makes them uniquely suited to these applications, providing lower contamination risks and reduced validation requirements.

Read more...

On Demand Webcast
Just Systems
  Complex Documents in the Pharmaceutical Industry Made Easy

Complex Documents in the Pharmaceutical Industry Made Easy Documents are created just about everywhere in the pharmaceutical industry. To manage interrelated documents, collaboratively created and updated, versioned and published to different targets can often turn into a nightmare. With XML authoring, recurrent tasks such as applying repetitive changes to similar documents or assuring quality for cross-referencing, can finally be automated.

Read more...

Podcast
Vetter
  Vetter Development Service Chicago
Peter Soelkner Managing Director,
Vetter Pharma International GmbH


Listen to this podcast recorded live from the show floor of AAPS 2009. Clinical development is key for new drugs. In order to minimize risks and take advantage of opportunities, you need comprehensive know-how and years of experience. Vetter, as a specialist in the aseptic filling of injection systems, will provide with its new facility the manufacturing of preclinical, Phase I and Phase II clinical batches in Chicago. We invite you to find out more about Vetter Development Services USA Inc.

Read More...

Key Topic Updates
Upcoming events
Organic Process Research and Development (19–22 January | USA)
BioBusiness 2010 (19–20 January | UK)
Pharmapack 2010 (1–2 February | France)
More events
 
Latest blog posts
Vetter Development Service Goes Live in Chicago
The Pharma 2.0 Trend For 2010
Gearing Up for Another Round in Healthcare Reform
More blog posts
Latest peer-reviewed research
A Robust, Automated Karl Fischer Titration System
Developing a modified Pulsincap system
Defining the ideal properties of a moisture protective, instant release film coating
More articles

Key Topic Updates

Survey
Which segment of drug delivery technologies offers the most exciting innovations?
  Injectable
  Inhalable
  Oral
  Topical

This week we would like to know...

Which area of oral drug delivery offers the most exciting innovation?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected]or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.